Filtros de búsqueda

Lista de obras de

Angiopoietins-1 and -2 are differentially expressed in the sera of patients with systemic sclerosis: high angiopoietin-2 levels are associated with greater severity and higher activity of the disease

artículo científico publicado el 10 de diciembre de 2010

CD163 and its role in inflammation

artículo científico

Diminished production of TWEAK by the peripheral blood mononuclear cells is associated with vascular involvement in patients with systemic sclerosis

artículo científico publicado en 2009

Eicosanoid production in the peripheral blood mononuclear cells (PBMC) from patients with systemic sclerosis

artículo científico publicado en 2008

High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis

artículo científico publicado en 2013

Increased production of a proliferation-inducing ligand (APRIL) by peripheral blood mononuclear cells is associated with antitopoisomerase I antibody and more severe disease in systemic sclerosis

artículo científico publicado en 2010

Increased release of soluble CD163 by the peripheral blood mononuclear cells is associated with worse prognosis in patients with systemic sclerosis

artículo científico publicado en 2013

OP0090 Serum CD163/Tweak Ratio Predicts Clinical Course of Digital Ulcers in Patients with Systemic Sclerosis

artículo científico publicado en 2014

Peripheral blood mononuclear cells from patients with systemic sclerosis spontaneously secrete increased amounts of vascular endothelial growth factor (VEGF) already in the early stage of the disease

artículo científico publicado en 2011

Recent advances in the diagnosis and treatment of systemic sclerosis.

artículo científico publicado en 2013

SAT0024 Increased production of leukotrienes by peripheral blood mononuclear cells is associated with more severe disease and worse prognosis in patients with systemic sclerosis

artículo científico publicado en 2013

The arachidonate 5-lipoxygenase activating protein gene polymorphism is associated with the risk of scleroderma-related interstitial lung disease: a multicentre European Scleroderma Trials and Research group (EUSTAR) study.

artículo científico publicado en 2017